Proventigen, a Reno, Nevada, based nutraceutical company, today announced that the company has entered into a long-term licensing agreement with Verdure Sciences to use Longvida® Optimized Curcumin, a highly absorbable Curcumin compound developed by a prestigious team of Southern California medical researchers studying Alzheimer’s disease.
In addition to the Longvida® Optimized Curcumin licensing agreement, Proventigen announced it has signed a licensing agreement to use POMELLA®, a natural and patented pomegranate extract in its product line. POMELLA® was also developed by leading medical researchers in an effort to have a reproducible and superior absorbing pomegranate extract.
Proventigen’s proprietary formulations feature ingredients with superior absorption profiles that focus on Brain Health, Breast/Prostate Health, Colon Health and Joint Health.
Both Longvida® Optimized Curcumin and POMELLA® pomegranate extract are used in Proventigen’s Selective Response Modulators™ (SRM) formula, the company’s flagship product.
“A elite team of medical researchers from a prestigious Southern California Medical School, discovered a natural and patented process to enhance Curcumin’s absorption and deliver it to the blood stream and brain at meaningful and therapeutic levels all without the use of piperine, a black pepper extract that can interfere with the metabolism of many drugs,” said Dr. Michael Nelson, Chief Science Officer, Proventigen. “We looked at numerous Curcumin extracts during our search to create Proventigen SRM™, and Longvida® Optimized Curcumin stood heads and tails above the rest.”
Researchers from around the globe have been feverishly trying to develop new methods to allow Curcumin to better absorb in the human body due to the Curcumin’s ability to influence some of the major pathways associated with Alzheimer’s disease, Cancer and Inflammation.
Longvida® Optimized Curcumin has 65 times the absorption of other Curcumin products and was shown in laboratory studies to cross the blood brain barrier. These findings spurred funding for two National Institutes of Health (NIH) studies looking at Alzheimer’s disease and the use of Longvida® Optimized Curcumin. Researchers at a leading Southern California School of Medicine have been working to develop Longvida® Optimized Curcumin with high absorption for more than two years before they were able to demonstrate their positive findings
POMELLA® is a natural and patented pomegranate extract that has superior absorption levels and antioxidant capacity compared to other pomegranate extract or pills on the market today. POMELLA® has been shown to increase antioxidant support in humans by over 30% in 30 minutes after ingestion. Unlike other pomegranate products, POMELLA® contains high levels of polyphenol antioxidants that will not breakdown due to its patented natural composition.
“Pomegranates polyphenols have a profound influence on key pathways that we are interested in such as aromatase, quinone reductase and CYP1B1 — all which we target in Proventigen SRM™,” added Nelson. “POMELLA® is the ultimate phytochemical and has been clinically researched to show that its punicalagins are preserved, enter the body intact, and are able to release ellagic acid into the bloodstream. No other pomegranate pill or extract on the market even comes close to matching POMELLA®.”
Proventigen Selective Response Modulators™ (SRM) formula contains a proprietary blend of patent-pending Longvida® Optimized Curcumin, patented POMELLA® pomegranate extract, N-aceytlcysteine (NAC) and B-vitamins including Folinic Acid, Methylcobalamin and B6. This unique blend of pharmaceutical grade compounds support pathways to optimal health!
To learn more about Proventigen and Proventigen SRM™, visit www.proventigen.com or call 1-888-537-2112.
